Clinical trial
A Double-blind, Placebo-controlled Pilot Trial of BP1.4979 for the Treatment of Binge Eating Disorder
NCT05118906 is registered in ClinicalTrials.gov with Bioprojet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Placebo-controlled Pilot Trial of BP1.4979 for the Treatment of Binge Eating Disorder
- Lead sponsor
- Bioprojet
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 7, 2022
- Completion date
- August 21, 2025
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.